Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Simone Finocchiaro"'
Autor:
Antonio Greco, Sabrina Scilletta, Denise Cristiana Faro, Federica Agnello, Maria Sara Mauro, Claudio Laudani, Giovanni Occhipinti, Marco Spagnolo, Carla Rochira, Simone Finocchiaro, Placido Maria Mazzone, Nicola Ammirabile, Davide Landolina, Antonino Imbesi, Davide Capodanno
Publikováno v:
The American Journal of Cardiology. 199:7-17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40dfac82f18ebeb1482168b90f6e8873
https://doi.org/10.1016/j.amjcard.2023.04.036
https://doi.org/10.1016/j.amjcard.2023.04.036
Autor:
Antonio Greco, Claudio Laudani, Marco Spagnolo, Federica Agnello, Denise Cristiana Faro, Simone Finocchiaro, Marco Legnazzi, Maria Sara Mauro, Placido Maria Mazzone, Giovanni Occhipinti, Carla Rochira, Lorenzo Scalia, Davide Capodanno
Publikováno v:
Circulation. 147:897-913
Therapeutic anticoagulation is indicated for a variety of circumstances and conditions in several fields of medicine to prevent or treat venous and arterial thromboembolism. According to the different mechanisms of action, the available parenteral an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3f3e424edf60116c4c0a99ceaaec305
https://doi.org/10.1161/circulationaha.122.062353
https://doi.org/10.1161/circulationaha.122.062353
Publikováno v:
Expert Opinion on Pharmacotherapy. 24:453-471
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6b452fb1649d070de9277ceaea41aad
https://doi.org/10.1080/14656566.2023.2171788
https://doi.org/10.1080/14656566.2023.2171788
Publikováno v:
European Heart Journal Supplements. 24
Background A number of clinical trials documented clinical benefits of glycoprotein IIb-IIIa inhibitors (GPIs) in the setting of acute coronary syndromes (ACS). The advantage of reducing thrombotic burden at the cost of a higher risk of bleeding has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::966587ccfee492f070692da416d01d56
https://doi.org/10.1093/eurheartjsupp/suac121.328
https://doi.org/10.1093/eurheartjsupp/suac121.328
Autor:
Marco Spagnolo, Claudio Laudani, Giovanni Occhipinti, Federica Agnello, Marco Legnazzi, Lorenzo Scalia, Maria Sara Mauro, Carla Rochira, Simone Finocchiaro, Antonio Greco, Davide Capodanno
Publikováno v:
European Heart Journal Supplements. 24
Introduction Patients with chronic coronary syndrome (CCS) can initially undergo an invasive (i.e., early referral to invasive coronary angiography [ICA]) or a conservative (i.e., anatomical or functional testing before ICA) management. The ISCHEMIA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e16dd6e214d0d4ea5dedfd462943874d
https://doi.org/10.1093/eurheartjsupp/suac121.547
https://doi.org/10.1093/eurheartjsupp/suac121.547
Autor:
Maria Sara Mauro, Federica Agnello, Simone Finocchiaro, Marco Legnazzi, Lorenzo Scalia, Davide Capodanno, Corrado Tamburino
Publikováno v:
European Heart Journal Supplements. 24
Background Antiplatelet therapy is required in patients with atherosclerotic coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) with drug-eluting stents (DES). Current European and American guidelines recommend 6 months
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a937536d748e5bedbd8a30356863382
https://doi.org/10.1093/eurheartjsupp/suac121.346
https://doi.org/10.1093/eurheartjsupp/suac121.346